Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 8.60
+0.03 (0.35%)
Feb 3, 2026, 1:25 PM CST
Tonghua Dongbao Pharmaceutical Company Description
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China.
It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine.
The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education.
In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metformin hydrochloride tablets.
Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Tonghua Dongbao Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1985 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,410 |
| CEO | Chun Sheng Leng |
Contact Details
Address: Dongbao New Village Tonghua, 134123 China | |
| Phone | 86 43 5508 8008 |
| Website | thdb.com |
Stock Details
| Ticker Symbol | 600867 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000H87 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chun Sheng Leng | Vice Chairman and GM |
| Junyu Chi | Chief Accountant |
| Guodong Zhang | Deputy GM and Director |
| Wenhai Zhang | Deputy GM and Director |
| Fan Su | Board Secretary |